Lista de obras - Bjorn Eliasson - Dominio Público Uruguay

A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes

artículo científico publicado en 2020

A method to predict the metabolic effects of changes in insulin treatment in subgroups of a large population based patient cohort

artículo científico publicado en 2007

A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR).

artículo científico publicado en 2011

Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register

artículo científico publicado en 2011

Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes

artículo científico publicado en 2014

Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone

artículo científico publicado en 2011

Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register

artículo científico publicado en 2013

Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients

artículo científico publicado en 2014

Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.

artículo científico publicado en 2007

Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register

artículo científico publicado en 2013

Association Between Socioeconomic Status and Mortality, Cardiovascular Disease, and Cancer in Patients With Type 2 Diabetes

artículo científico publicado en 2016

Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes

artículo científico publicado en 2016

Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.

artículo científico publicado en 2018

Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register

scientific article published on 01 February 2011

Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II)

artículo científico publicado en 2012

Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register

artículo científico publicado en 2015

Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey

scientific article published on 14 May 2019

Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.

artículo científico publicado en 2016

Cephalic phase of insulin secretion in response to a meal is unrelated to family history of type 2 diabetes

artículo científico publicado en 2017

Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study

artículo científico publicado en 2017

Cigarette smoking and diabetes.

artículo científico publicado en 2003

Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study

artículo científico publicado en 2016

Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register

artículo científico publicado en 2011

Connections between risk factors and complications in diabetes. A report after 13 years with the National Diabetes Registry (NDR)

artículo científico publicado en 2009

Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.

artículo científico publicado en 2016

Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in sweden

artículo científico publicado en 2014

Different methods to present the effect of blood pressure on cardiovascular diseases by Cox regression

artículo científico publicado en 2012

Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients

artículo científico publicado en 2015

Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR).

artículo científico publicado en 2015

Early Clinical Indicators of Addison’s Disease in Adults with Type 1 Diabetes: a Nationwide, Observational, Cohort Study

artículo científico publicado en 2018

Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels

artículo científico publicado en 2015

Effect of smoking reduction and cessation on cardiovascular risk factors.

artículo científico publicado en 2001

Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

artículo científico publicado en 2009

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register

artículo científico publicado en 2012

Efficacy and Safety of Treatment with New Basal Insulin Analogues in Type 1 Diabetes: Nation-Wide Survey

artículo científico publicado en 2020

Electrical atrial vulnerability and renal complications in type 2 diabetes. Reply to Montaigne D, Coisne A, Sosner P et al [letter].

artículo científico publicado en 2016

Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting.

artículo científico publicado en 2016

Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial

artículo científico publicado en 2016

Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting

artículo científico publicado en 2015

Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register

scientific article published on 01 March 2007

Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). ⬇️

artículo científico publicado en 2010

HbA1C and cancer risk in patients with type 2 diabetes--a nationwide population-based prospective cohort study in Sweden

artículo científico publicado en 2012

Health utilities of type 2 diabetes-related complications: a cross-sectional study in Sweden

artículo científico publicado en 2014

Impact of ethnicity on progress of glycaemic control in 131,935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register

artículo científico publicado en 2015

Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from Type II diabetic subjects

artículo científico publicado en 2000

Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.

artículo científico publicado en 2012

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study

artículo científico publicado en 2015

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes

artículo científico publicado en 2015

LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.

artículo científico publicado en 2013

Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register

scientific article published on 13 November 2013

Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment.

artículo científico publicado en 2012

Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting

artículo científico publicado en 2015

Metabolic effects of Basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: registry-based observational study in clinical practice.

artículo científico publicado en 2014

Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.

artículo científico publicado en 2015

Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.

artículo científico publicado en 2005

Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.

artículo científico publicado en 2016

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)

artículo científico publicado en 2010

Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register.

artículo científico publicado en 2006

Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population

artículo científico publicado en 2012

Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.

artículo científico publicado en 2005

Persistence with IDegLira in Patients in Clinical Practice: A Nationwide Observational Study in Sweden

artículo científico publicado en 2020

Potential Benefits and Harms of Gastric Bypass Surgery in Obese Individuals With Type 1 Diabetes: A Nationwide, Matched, Observational Cohort Study

artículo científico publicado en 2020

Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.

artículo científico publicado en 2014

Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR).

artículo científico publicado en 2009

Recent trends in life expectancy for people with type 1 diabetes in Sweden.

artículo científico publicado en 2016

Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study

artículo científico

Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus

artículo científico publicado en 2015

Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR).

artículo científico publicado en 2015

Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR).

artículo científico publicado en 2010

Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients

artículo científico publicado en 2008

Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register

artículo científico publicado en 2008

Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden

artículo científico publicado en 2014

Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register

artículo científico publicado en 2009

Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register

artículo científico publicado en 2010

The Impact of Empagliflozin on Obstructive Sleep Apnea, Cardiovascular, and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 01 October 2020

The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes

artículo científico publicado en 2014

The effect of insulin lispro on glycemic control in a large patient cohort.

artículo científico publicado en 2009

The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003

artículo científico publicado en 2005

The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.

artículo científico publicado en 2011

The role of chloramines in treatment of diabetic foot ulcers: an exploratory multicentre randomised controlled trial

artículo científico publicado en 2016

The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients

artículo científico publicado en 2012

The triglycerides-to-HDL-cholesterol ratio and cardiovascular disease risk in obese patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)

artículo científico publicado en 2014

The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables.

artículo científico publicado en 2009

Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis.

artículo científico publicado en 2009

Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008

artículo científico publicado en 2012

Total costs of basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: register-based observational study in clinical practice

artículo científico publicado en 2015

Use of Glucagon-Like Peptide 1 Receptor Agonists and Risk of Serious Renal Events: Scandinavian Cohort Study

scientific article published on 15 April 2020

Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.

artículo científico publicado en 2011

Lista de obras de Bjorn Eliasson

A Patient-Level Model to Estimate Lifetime Health Outcomes of Patients With Type 1 Diabetes

A method to predict the metabolic effects of changes in insulin treatment in subgroups of a large population based patient cohort

A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR).

Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register

Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes

Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazone

Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register

Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients

Antihyperglycaemic treatment of type 2 diabetes: results from a national diabetes register.

Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register

Association Between Socioeconomic Status and Mortality, Cardiovascular Disease, and Cancer in Patients With Type 2 Diabetes

Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes

Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.

Blood lipids in 75,048 type 2 diabetic patients: a population-based survey from the Swedish National diabetes register

Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II)

Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register

Cardiovascular Disease in Patients with Type 2 Diabetes and in Patients Starting Empagliflozin Treatment: Nationwide Survey

Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register.

Cephalic phase of insulin secretion in response to a meal is unrelated to family history of type 2 diabetes

Changes in risk factors and their contribution to reduction of mortality risk following gastric bypass surgery among obese individuals with type 2 diabetes: a nationwide, matched, observational cohort study

Cigarette smoking and diabetes.

Clinical Effects and Safety of Direct-Acting Insulin Analogs in Patients with Type 1 Diabetes: A Nation-Wide Observational Cohort Study

Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register

Connections between risk factors and complications in diabetes. A report after 13 years with the National Diabetes Registry (NDR)

Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.

Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in sweden

Different methods to present the effect of blood pressure on cardiovascular diseases by Cox regression

Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients

Durability of oral hypoglycemic agents in drug naïve patients with type 2 diabetes: report from the Swedish National Diabetes Register (NDR).

Early Clinical Indicators of Addison’s Disease in Adults with Type 1 Diabetes: a Nationwide, Observational, Cohort Study

Effect of 3 Years of Treatment With Exenatide on Postprandial Glucagon Levels

Effect of smoking reduction and cessation on cardiovascular risk factors.

Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register

Efficacy and Safety of Treatment with New Basal Insulin Analogues in Type 1 Diabetes: Nation-Wide Survey

Electrical atrial vulnerability and renal complications in type 2 diabetes. Reply to Montaigne D, Coisne A, Sosner P et al [letter].

Estimated glucose disposal rate and long-term survival in type 2 diabetes after coronary artery bypass grafting.

Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial

Glycemic Control in Type 1 Diabetes and Long-Term Risk of Cardiovascular Events or Death After Coronary Artery Bypass Grafting

Glycemic and risk factor control in type 1 diabetes: results from 13,612 patients in a national diabetes register

Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR). ⬇️

HbA1C and cancer risk in patients with type 2 diabetes--a nationwide population-based prospective cohort study in Sweden

Health utilities of type 2 diabetes-related complications: a cross-sectional study in Sweden

Impact of ethnicity on progress of glycaemic control in 131,935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register

Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from Type II diabetic subjects

Increased Urine IgM and IgG(2) Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes.

Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study

LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes

LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.

Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register

Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: the impact of glucose-lowering treatment.

Long-term prognosis in patients with type 1 and 2 diabetes mellitus after coronary artery bypass grafting

Metabolic effects of Basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: registry-based observational study in clinical practice.

Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.

Microalbuminuria and risk factors in type 1 and type 2 diabetic patients.

Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR)

Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register.

Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population

Optimization of basal insulin delivery in Type 1 diabetes: a retrospective study on the use of continuous subcutaneous insulin infusion and insulin glargine.

Persistence with IDegLira in Patients in Clinical Practice: A Nationwide Observational Study in Sweden

Potential Benefits and Harms of Gastric Bypass Surgery in Obese Individuals With Type 1 Diabetes: A Nationwide, Matched, Observational Cohort Study

Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.

Pulse pressure strongly predicts cardiovascular disease risk in patients with type 2 diabetes from the Swedish National Diabetes Register (NDR).

Recent trends in life expectancy for people with type 1 diabetes in Sweden.

Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study

Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus

Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR).

Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR).

Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients

Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register

Severe hypoglycemia and mortality after cardiovascular events for type 1 diabetic patients in Sweden

Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register

Systolic blood pressure and risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish national diabetes register

The Impact of Empagliflozin on Obstructive Sleep Apnea, Cardiovascular, and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial

The effect of alogliptin and pioglitazone combination therapy on various aspects of β-cell function in patients with recent-onset type 2 diabetes

The effect of insulin lispro on glycemic control in a large patient cohort.

The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003

The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.